OSHA SearchOSHA records by employer

Quva Pharma, Inc: OSHA inspections and violations

Bloomsbury, New Jersey · Pharmaceutical Preparation Manufacturing · NAICS 325412

2inspections
6citation items
$67,500current penalties
Jun 27, 2024last inspection

Since 2022, OSHA inspectors have visited Quva Pharma, Inc in New Jersey 2 times.

The most recent inspection opened on Jun 27, 2024 after a complaint, in Bloomsbury.

In all, OSHA issued 6 citation items: 6 serious.

The proposed penalties came to $163,625; today they stand at $67,500, 59% less.

The rule cited most here is 1910.134 (respiratory protection), 4 times.

Among manufacturing employers, the typical cited inspection since 2015 ends with a $4,500 penalty. Quva Pharma, Inc averages $67,500 across 1 cited inspection.

Quva Pharma, Inc also files yearly injury logs with OSHA, summarized below.

Quva Pharma, Inc: OSHA citation items per year, 2022 to 2024
Citation items per year, by inspection date.

Want to know if OSHA cites Quva Pharma, Inc again? Add it to a watchlist and we will email you the morning the citation shows up.

Watch this company

Inspection history

Inspection 347582280 OPENED JUN 27, 2024Closed

Complaint · Partial · Health · 570 employees at the site · Closed Dec 12, 2025

519 State Route 173, Bloomsbury, NJ 08804 · Pharmaceutical Preparation Manufacturing · OSHA's record · Phone and website on Google Maps

Citation and ruleTypeProposedCurrentIssuedStatus
Citation 1, item 1a
29 CFR 1910.134(c)(1) · Respiratory protection
Serious$11,524$11,524Dec 23, 2024Final
Citation 1, item 1b
29 CFR 1910.134(e)(1) · Respiratory protection
Serious$0$0Dec 23, 2024Final
Citation 1, item 1c
29 CFR 1910.134(k) · Respiratory protection
Serious$0$0Dec 23, 2024Final
Citation 1, item 2
29 CFR 1910.134(d)(3)(ii) · Respiratory protection
Serious$13,828$13,828Dec 23, 2024Final
Citation 2, item 1a
29 CFR 1910.1000(a)(2) · Air contaminants
Serious$138,273$42,148Dec 23, 2024Final
Citation 2, item 1b
29 CFR 1910.1000(e) · Air contaminants
Serious$0$0Dec 23, 2024Final

Inspection 346201486 OPENED SEP 7, 2022Closed

Complaint · Partial · Health · 380 employees at the site · Closed Mar 7, 2023

519 State Route 173, Bloomsbury, NJ 08804 · Pharmaceutical Preparation Manufacturing · OSHA's record · Phone and website on Google Maps

No citations from this inspection.

Injury and illness logs

From the Form 300A summaries employers file with OSHA each year. Rate = recordable cases per 100 full-time workers.

In 2025, the Bloomsbury site logged 7 recordable injuries or illnesses among about 486 workers: 1.5 per 100 full-time workers, against a median of 1.1 for its industry.

Site and yearWorkersCasesDays-away casesRateIndustry median
QuVa Pharma Inc.
Bloomsbury · 2025
486 701.51.1
QuVa Pharma Bloomsbury
Bloomsbury · 2019
193 29517.41.1

The rules behind these citations

Current text from the Code of Federal Regulations. Some citations were issued under older wording.

29 CFR 1910.1000 · Air contaminants

29 CFR 1910.1000(a)(2)

(2) Other substances—8-hour Time Weighted Averages. An employee's exposure to any substance in Table Z-1, the exposure limit of which is not preceded by a “C”, shall not exceed the 8-hour Time Weighted Average given for that substance in any 8-hour work shift of a 40-hour work week.

29 CFR 1910.1000(e)

(e) To achieve compliance with paragraphs (a) through (d) of this section, administrative or engineering controls must first be determined and implemented whenever feasible. When such controls are not feasible to achieve full compliance, protective equipment or any other protective measures shall be used to keep the exposure of employees to air contaminants within the limits prescribed in this section. Any equipment and/or technical measures used for this purpose must be approved for each particular use by a competent industrial hygienist or other technically qualified person. Whenever respirators are used, their use shall comply with 1910.134.

29 CFR 1910.134 · Respiratory protection

29 CFR 1910.134(c)(1)

(1) The test instrument must have an effective audio-warning device, or a visual-warning device in the form of a screen tracing, that indicates when the test subject fails to hold his or her breath during the test. The test must be terminated and restarted from the beginning when the test subject fails to hold his or her breath during the test. The test subject then may be refitted and retested.

Other pharmaceutical preparation manufacturing employers in New Jersey

Source: U.S. Department of Labor, OSHA enforcement data. A citation is OSHA's allegation; employers can contest it, and the status column shows where each item stands. Something wrong on this page? Tell us.